Clinical Trial Update: Metformin Prostate Cancer Adjuvant Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on metformin as adjuvant therapy in prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostate Cancer Recurrent

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: NYU Langone Health | Conditions: Prostate Cancer, Prostate Cancer Recurrent | Phase 2 | Status: COMPLETED | Results posted: 2022-10-18